Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Ginkgo Bioworks Holdings Analyst Ratings
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $7
Ginkgo Bioworks Holdings: Sell Rating Affirmed With Revised Valuation and Price Target
Express News | Ginkgo Bioworks Holdings Inc : Btig Adjusts Target Price to $7 From $0.2 to Reflect 1-for-40 Reverse Stock Split
Why We're Not Concerned Yet About Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) 31% Share Price Plunge
Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $40
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD)
Ginkgo Bioworks Announces Reverse Stock Split
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
Ginkgo Bioworks Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Ginkgo Bioworks: Hold Rating Maintained Amid Revenue Uncertainty and Restructuring Challenges
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Latest 23% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
Ginkgo Bioworks: Underperform Rating Due to Financial Strain and Uncertain Strategic Outcomes
Express News | Ginkgo Bioworks Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Revenue Results
Express News | Ginkgo Bioworks Holdings Qtrly Shr Loss $0.11
Express News | Ginkgo Bioworks Holdings Inc: Reaffirms Total Revenue of $170-$190 Mln in 2024